And we believe there is a place for mandatory serious adverse events reporting related to these substances. What could the future look like
BPC-157 For Knee Pain: Early Reported Outcomes A report on intra-articular BPC-157 for knee pain described high rates of improvement: ~92% with BPC-157 alone, ~75% when combined with thymosin beta-4, and overall pain relief reported in 87.5% of patients
An initial consultation establishes injury history, inflammatory markers, and organ function before any protocol is designed
Easy measuring: At 12.5 mg/mL, 1 unit = 0.01 mL = 0.125 mg (125 mcg) on a U-100 insulin syringe
Can this product be used in humans or animals
Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tracts, Wound Healing, and Central Nervous System. Current Pharmaceutical Design , 2018